1. home >
2. Library (Papers/Data) >
3. Scientific Papers >
4. Archived Scientific Papers (until 2019) >
5. Technical Report Series (1959-1992) >
6. Technical Report Series, 1992

Technical Report Series, 1992

• Technical Report No. 1-92

  Technical Report No. 1-92

  Adult Health Study Report 7. Noncancer disease incidence in the atomic-bomb survivors, 1958-86 (examination cycles 1-14)

  • Full text
  • Summary

• Technical Report No. 2-92

  Technical Report No. 2-92

  Monoclonal gammopathy in atomic bomb survivors

  • Summary

• Technical Report No. 3-92

  Technical Report No. 3-92

  Unique association of p53 mutations with undifferentiated but not with differentiated thyroid gland carcinomas

  • Full text
  • Summary

• Technical Report No. 4-92

  Technical Report No. 4-92

  Autoantibodies and immunoglobulins among atomic-bomb survivors

  • Full text
  • Summary

• Technical Report No. 5-92

  Technical Report No. 5-92

  Cancer incidence in atomic bomb survivors. Part II: Solid tumors ,1958-1987

  • Summary

• Technical Report No. 6-92

  Technical Report No. 6-92

  Radiation-related small head sizes among prenatally exposed atomic bomb survivors

  • Full text
  • Summary

• Technical Report No. 7-92

  Technical Report No. 7-92

  Restricted expression of recombination activating gene (RAG-1) in mouse lymphoid tissues

  • Full text
  • Summary

• Technical Report No. 8-92

  Technical Report No. 8-92

  Dose survival of G₀ lymphocytes irradiated in vitro: A test for a possible population bias in the cohort of atomic-bomb survivors exposed to high doses

  • Full text
  • Summary

• Technical Report No. 9-92

  Technical Report No. 9-92

  Proliferative and nonproliferative breast disease in atomic-bomb survivors: Results of a histopathology review of autopsy breast tissue

  • Full text
  • Summary

• Technical Report No. 10-92

  Technical Report No. 10-92

  Radiosensitivity of atomic bomb survivors as determined with a micronucleus assay

  • Summary

• Technical Report No. 11-92

  Technical Report No. 11-92

  Radiation cataracts among Hiroshima atomic-bomb survivors, 1949-64

  • Full text
  • Summary

• Technical Report No. 12-92

  Technical Report No. 12-92

  Thyroid diseases among atomic bomb survivors in Nagasaki

  • Summary

• Technical Report No. 13-92

  Technical Report No. 13-92

  Stable chromosome aberrations among A-bomb survivors: An update

  • Summary

• Technical Report No. 14-92

  Technical Report No. 14-92

  Study of the titers of anti-Epstein-Barr virus antibodies in the sera of atomic bomb survivors

  • Summary

• Technical Report No. 15-92

  Technical Report No. 15-92

  Colorectal cancer incidence among atomic bomb survivors, 1950-80

  • Summary

• Technical Report No. 16-92

  Technical Report No. 16-92

  Rapid translocation frequency analysis in humans decades after exposure to ionizing radiation

  • Full text
  • Summary

• Technical Report No. 17-92

  Technical Report No. 17-92

  A novel blocker-PCR method for detection of rare mutant alleles in the presence of an excess amount of normal DNA

  • Summary

• Technical Report No. 18-92

  Technical Report No. 18-92

  Levels of parathyroid hormone and calcitonin in serum among atomic bomb survivors

  • Summary

• Technical Report No. 19-92

  Technical Report No. 19-92

  A longitudinal study of growth and development among prenatally exposed atomic-bomb survivors

  • Full text
  • Summary

• Technical Report No. 20-92

  Technical Report No. 20-92

  Radiation-associated lung cancer: A comparison of the histology of lung cancers in uranium miners and survivors of the atomic bombings of Hiroshima and Nagasaki

  • Summary

• Technical Report No. 21-92

  Technical Report No. 21-92

  Variations among Japanese of the factor IX gene (F9) detected by PCR-denaturing gradient gel electrophoresis

  • Summary

• Technical Report No. 22-92

  Technical Report No. 22-92

  Accurate and rapid detection of heterozygous carriers of a deletion by combined polymerase chain reaction and high-performance liquid chromatography

  • Summary

• Technical Report No. 23-92

  Technical Report No. 23-92

  Immune responses to Epstein-Barr virus in atomic bomb survivors: Study of precursor frequency of cytotoxic lymphocytes and titer levels of anti-Epstein-Barr virus-related antibodies

  • Summary

• Technical Report No. 24-92

  Technical Report No. 24-92

  Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987

  • Summary

戻る